News » MHRA alert » Alert: Hiprex 1g tablets
April 23rd 2026
Doncaster Pharma has issued an alert relating to five batches of Hiprex 1g tablets (methenamine hippurate).
The affected batches are not being recalled. These are:
|
Batch No. |
Expiry Date |
Pack Size |
First Distributed |
|
251352/BA |
04/2028 |
100 tablets |
27/10/2025 |
|
251358/BA |
04/2028 |
100 tablets |
21/01/2026 |
|
252137/BA |
04/2028 |
100 tablets |
04/02/2026 |
|
252137/BB |
04/2028 |
100 tablets |
11/03/2026 |
|
251358/BB |
04/2028 |
100 tablets |
27/03/2026 |
The error relates to the Braille embossing on the outer packaging of the affected parallel imported batches of Hiprex 1g tablets (POM). This incorrectly states the strength as 1mg. The printed text on the outer packaging, immediate packaging and Patient Information Leaflet (PIL) correctly state the strength as 1g.
Dispensary teams are asked to explain the Braille errors to patients who rely solely on Braille when reading medicine cartons, if required. There is no risk of dosing errors arising from the Braille issue.
No action is needed from patients,
For all medical information enquiries and information on this product, please email regulatory@doncasterpharma.co.uk or quality.enquiries@doncasterpharma.co.uk, or telephone 01302 365 000.
For stock control enquiries, please email commercial@doncasterpharma.co.uk, or telephone 01302 365 000.
